Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Benitec Selects University of California, San Diego, as a Site for Phase I/II Clinical Trial of TT‐034


Guru

Status: Offline
Posts: 5627
Date:
Benitec Selects University of California, San Diego, as a Site for Phase I/II Clinical Trial of TT‐034
Permalink  
 


Benitec Selects University of California, San Diego, as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections

SYDNEY, April 15, 2013 /PRNewswire/ -- RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego (UCSD), Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections (HCV).  Benitec previously announced the selection of Duke Clinical Research Unit as the other site. 

TT-034 is being developed as a potential "one-shot-cure" for HCV.

Link to article...

http://hcvadvocate.blogspot.ca/2013/04/benitec-selects-university-of.html



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.